Skip to content
Recall Observatory FDA recall evidence

Device product

is a quantitative/qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of IgG and IgM autoantibodies specific for the phospholipid cardiolipin in human serum and EDTA, lithium heparin or citrated plasma. It is intended to assess of anti-cardiolipin IgG autoantibody levels in patients where this information is useful in diagnosis, particularly in the assessment of thrombotic risk in patients with systemic lupus erythematosus, or other lupus-like disorders

Z-2920-2018

October 21, 2016

Class III

Product summary

Firm
Euro Diagnostica AB
Event
Event 80684
Status
Terminated
Classification
Class III
Quantity
6
Official record key
device-enforcement:Z-2920-2018

Official wording

Reason: Incorrectly labeled Manufactured by DiaSorin, The correct term should be Distributed by DiaSorin.

Code information: Lot #'s: TS 2783 (kit) and TS 2787 (PC)

Distribution pattern: MN

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Incorrectly labeled